NASDAQ : PDEX
Pro-Dex, Inc. — Key statistics
Healthcare · Medical Instruments & Supplies · United States
Last price 61.6 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 197.33M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 184.48M |
| Enterprise Value | 189.98M |
Dates
| Measure | Value |
|---|
| Earnings Date | Oct 29, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 3.20M |
| Shares Outstanding | 3.20M |
| Shares Change (YoY) | -1.83% |
| Shares Change (QoQ) | +0.64% |
| Owned by Insiders (%) | 15.90% |
| Owned by Institutions (%) | 23.95% |
| Float | 1.49M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 15.85 |
| Forward PE | 18.13 |
| PS Ratio | 2.38 |
| Forward PS | 2.26 |
| PB Ratio | 3.78 |
| P/TBV Ratio | 4.49 |
| P/FCF Ratio | 17.69 |
| P/OCF Ratio | 16.55 |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 16.17 |
| EV / Sales | 2.45 |
| EV / EBITDA | 13.07 |
| EV / EBIT | 14.52 |
| EV / FCF | 18.20 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 4.19 |
| Quick Ratio | 2.45 |
| Debt / Equity | 0.38 |
| Debt / EBITDA | 1.22 |
| Debt / FCF | 1.78 |
| Interest Coverage | 15.36 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 26.48% |
| Return on Assets (ROA) | 11.89% |
| Return on Invested Capital (ROIC) | 18.87% |
| Return on Capital Employed (ROCE) | 21.03% |
| Weighted Average Cost of Capital (WACC) | 4.42% |
| Revenue Per Employee | $386,301 |
| Profits Per Employee | $58,398 |
| Employee Count | 206 |
| Asset Turnover | 1.13 |
| Inventory Turnover | 2.47 |
Taxes
| Measure | Value |
|---|
| Income Tax | 3.14M |
| Effective Tax Rate | 20.71% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.04 |
| 52-Week Price Change | +59.08% |
| 50-Day Moving Average | 64.61 |
| 200-Day Moving Average | 56.64 |
| Relative Strength Index (RSI) | 37.57 |
| Average Volume (20 Days) | 43,618 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 235,918 |
| Short Previous Month | 199,385 |
| Short % of Shares Out | 7.37% |
| Short % of Float | 15.80% |
| Short Ratio (days to cover) | 3.98 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 79.58M |
| Gross Profit | 25.83M |
| Operating Income | 13.40M |
| Pretax Income | 15.17M |
| Net Income | 12.03M |
| EBITDA | 14.88M |
| EBIT | 13.40M |
| Earnings Per Share (EPS) | $3.64 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 12.99M |
| Total Debt | 18.98M |
| Net Cash | -5.50M |
| Net Cash Per Share | -$1.72 |
| Equity (Book Value) | 49.35M |
| Book Value Per Share | 15.40 |
| Working Capital | 41.06M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 11.42M |
| Capital Expenditures | -731,000 |
| Depreciation & Amortization | 1.49M |
| Net Borrowing | 1.02M |
| Free Cash Flow | 10.69M |
| FCF Per Share | $3.34 |
Margins
| Measure | Value |
|---|
| Gross Margin | 32.45% |
| Operating Margin | 16.84% |
| Pretax Margin | 19.07% |
| Profit Margin | 15.12% |
| EBITDA Margin | 18.70% |
| EBIT Margin | 16.84% |
| FCF Margin | 13.43% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 1.83% |
| Shareholder Yield | 1.83% |
| Earnings Yield | 6.31% |
| FCF Yield | 5.65% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Jun 18, 2010 |
| Split Type | Reverse |
| Split Ratio | 1:3 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 6.7 |
| Piotroski F-Score | 5 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |